What is the difference between schizoaffective disorder and bipolar disorder with psychotic features?

The difference is whether psychosis ever happens outside a mood episode. In bipolar disorder with psychotic features, delusions and hallucinations occur only during manic or depressive episodes and stop when mood returns to normal. Schizoaffective disorder requires at least 2 weeks of delusions or hallucinations without any major mood episode at some point in the illness, plus mood episodes that fill the majority of the illness. A patient whose voices continue for weeks while mood is normal does not have bipolar disorder with psychotic features.

What is the 2-week rule in schizoaffective disorder?

The 2-week rule is DSM-5-TR Criterion B: at some point during the lifetime of the illness, the person must have delusions or hallucinations for 2 weeks or more without a major depressive or manic episode. It separates schizoaffective disorder from bipolar disorder or major depressive disorder with psychotic features, in which psychosis occurs only during mood episodes. The 2-week period can occur at any time in the illness, not necessarily at the current presentation.

How long do mood symptoms have to last in schizoaffective disorder?

Under DSM-5 and DSM-5-TR, symptoms that meet criteria for a major mood episode must be present for the majority, meaning more than half, of the total duration of the illness, counting both active and residual phases. Requiring a majority was the main DSM-5 change to this diagnosis, so study materials that say mood symptoms need only fill a substantial portion of the illness are out of date. The change made schizoaffective disorder a longitudinal diagnosis, so you judge the whole course of the illness rather than a single episode.

How is schizoaffective disorder different from schizophrenia?

Both include schizophrenia Criterion A symptoms such as delusions and hallucinations. In schizoaffective disorder, major mood episodes occur at the same time as the psychosis and are present for most of the illness, and there are also at least 2 weeks of psychosis without a mood episode. In schizophrenia, mood episodes are absent or occupy only a minority of the illness, and continuous signs of illness must last at least 6 months.

What medication is FDA-approved for schizoaffective disorder?

Paliperidone is the drug FDA-approved to treat schizoaffective disorder in adults: the oral extended-release tablet (Invega) and the monthly paliperidone palmitate injections (Invega Sustenna and Erzofri), alone or with mood stabilizers or antidepressants. The 3-month and 6-month paliperidone injections are labeled for schizophrenia only. Clozapine is approved to reduce the risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorder. Mood stabilizers and antidepressants are added off-label depending on the type.

What are the two types of schizoaffective disorder?

DSM-5-TR describes two types. The bipolar type applies when a manic episode is part of the illness, even if major depressive episodes also occur. The depressive type applies when only major depressive episodes occur. On exams, a single manic episode anywhere in the history makes the diagnosis schizoaffective disorder, bipolar type, so check the whole timeline before choosing the specifier.

Schizoaffective Disorder USMLE Question: The 2-Week Rule

Schizoaffective disorder is a major mood episode (manic or major depressive) occurring together with schizophrenia-type psychosis, plus at least 2 weeks of delusions or hallucinations with no mood episode at some point in the illness, with mood episodes present for the majority of the total illness (DSM-5-TR). If psychosis appears only inside mood episodes, the answer is bipolar I or major depressive disorder (MDD) with psychotic features; if mood episodes fill only a minority of the illness, it is a schizophrenia-spectrum diagnosis (schizophrenia once the illness has lasted 6 months). Any manic episode makes it the bipolar type; major depressive episodes alone make it the depressive type. Paliperidone (oral extended-release tablets and the monthly injection) is the drug FDA-approved to treat it.

The vignette

A 31-year-old woman is brought to the emergency department by her brother. For the past 10 days she has slept 2-3 hours a night, talked rapidly without pause and spent her savings on equipment for a "worldwide broadcasting network" she plans to run. She says two men's voices have commented on her actions for the past 14 months and that her neighbors are poisoning her water. Her brother reports that during those 14 months she also had a 6-month major depressive episode and a 2-month manic episode that needed hospitalization. Between episodes she spent several months with normal mood, but the voices and the poisoning belief never stopped. In total, mood episodes have filled about 8 of the 14 months. Urine drug screen and TSH are normal, and she takes no medications or supplements.

Which of the following is the most likely diagnosis?

A. Bipolar I disorder with psychotic features B. Brief psychotic disorder C. Major depressive disorder with psychotic features D. Schizoaffective disorder, bipolar type E. Schizoaffective disorder, depressive type F. Schizophrenia G. Schizophreniform disorder H. Substance/medication-induced psychotic disorder

Answer: D. Schizoaffective disorder, bipolar type

Walk the DSM-5-TR criteria one at a time:

Criterion	What DSM-5-TR requires	This patient
A	An uninterrupted illness with a major mood episode at the same time as schizophrenia Criterion A symptoms	Voices and a persecutory delusion during a major depressive episode and two manic episodes
B	Delusions or hallucinations for 2 weeks or more without a major mood episode, at any point in the lifetime illness	Several months of voices and delusions with normal mood
C	Symptoms of a major mood episode present for the majority (more than 50%) of the total illness, active and residual phases	About 8 of 14 months
D	Not caused by a substance, a medication or another medical condition	Normal drug screen and TSH, no medications

Schizophrenia Criterion A means 2 or more of delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior and negative symptoms, each present for a significant part of a 1-month period, with at least one of the first three. She has two (hallucinations and delusions).

The type: because a manic episode is part of the illness, it is the bipolar type, even though she has also had a major depressive episode.

Why every other answer choice is wrong

A. Bipolar I disorder with psychotic features. Tempting: textbook mania plus psychosis. Wrong: in bipolar disorder or MDD with psychotic features, delusions and hallucinations occur only during mood episodes. Months of voices with normal mood rule it out. It would be right if the voices stopped every time her mood returned to baseline.

B. Brief psychotic disorder. Psychotic symptoms last at least 1 day but less than 1 month, sometimes triggered by a major stressor such as the loss of a loved one, followed by a full return to premorbid functioning. She has been ill for 14 months. More on it in the brief psychotic disorder breakdown.

C. Major depressive disorder with psychotic features. A single manic episode excludes MDD, and her psychosis also runs outside mood episodes. Psychotic depression typically brings delusions of unpardonable sins or crimes, incurable or shameful disease, or persecution.

E. Schizoaffective disorder, depressive type. Right disorder, wrong specifier. The depressive type applies only when major depressive episodes alone occur; one manic episode anywhere in the history makes it the bipolar type.

F. Schizophrenia. Tempting: she meets Criterion A, and continuous signs have lasted well over 6 months. Wrong: in schizophrenia, mood episodes are absent or present for only a minority of the illness. Here they fill most of it.

G. Schizophreniform disorder. Schizophrenia symptoms lasting at least 1 month but less than 6 months. Her illness has lasted 14 months, and mood episodes dominate it.

H. Substance/medication-induced psychotic disorder. Needs a drug or medication that can cause psychosis, with symptoms that start during or soon after intoxication or withdrawal. Her drug screen is negative, she takes nothing, and the psychosis has run continuously for over a year. Classic culprits are cannabis and stimulants.

Three questions that sort every psychosis-plus-mood stem

Does psychosis ever occur without a mood episode? No: bipolar I or MDD with psychotic features. Yes, for 2 weeks or more: go to question 2.
Have major mood episodes been present for the majority of the illness? Yes: schizoaffective disorder. No: a schizophrenia-spectrum diagnosis, so go to question 3.
How long has the psychosis lasted? At least 1 day but under 1 month: brief psychotic disorder. 1 to under 6 months: schizophreniform disorder. 6 months or more: schizophrenia. Delusions alone for at least 1 month, with functioning largely intact: delusional disorder.

Then name the type: any manic episode = bipolar type; major depressive episodes only = depressive type.

Psychotic disorders compared

Disorder	Key requirement	Duration	Role of mood episodes
Brief psychotic disorder	Psychotic symptoms, then full return to baseline	1 day to under 1 month	Not part of the picture
Schizophreniform disorder	Schizophrenia Criterion A	1 month to under 6 months	Absent or brief
Schizophrenia	Criterion A plus decline in functioning	6 months or more of continuous signs, including 1 month of active symptoms	Absent or a minority of the illness
Schizoaffective disorder	Criterion A with a concurrent major mood episode, plus 2 weeks or more of psychosis without one	Judged across the whole illness	Majority of the illness
Delusional disorder	At least 1 delusion; never met Criterion A; no marked impairment or bizarre behavior	1 month or more	Brief compared with the delusional periods
Bipolar I or MDD with psychotic features	Delusions or hallucinations within mood episodes	Length of the mood episode	Psychosis only during mood episodes

For the other schizophrenia-spectrum diagnoses, see the schizophrenia positive vs negative symptoms breakdown.

Who gets it, and what changed in DSM-5

Lifetime prevalence is about 0.3%, roughly a third as common as schizophrenia, and it occurs more often in women (StatPearls).
DSM-5 added the "majority" rule. Its main change to schizoaffective disorder was requiring a major mood episode for the majority of the disorder's total duration, which makes schizoaffective disorder a longitudinal rather than cross-sectional diagnosis (APA). DSM-5-TR keeps the rule: more than 50% of the total duration, active and residual phases included (Merck). Study materials that say mood symptoms need only fill "a substantial portion" of the illness are out of date.
One snapshot is not enough. Separating it from schizophrenia and mood disorders may need longitudinal assessment (Merck); mania with psychosis seen at one visit cannot establish the diagnosis without the history of the whole illness.

Treatment: what is FDA-approved

Option	When it is used	FDA labeling
Paliperidone ER tablets (Invega)	Daily oral option (any second-generation antipsychotic can be the first drug)	Approved for schizoaffective disorder in adults, alone or with mood stabilizers and/or antidepressants; also schizophrenia (adults and ages 12-17)
Paliperidone palmitate monthly injection (Invega Sustenna, Erzofri)	Long-acting option, useful when adherence is the problem	Approved for schizoaffective disorder in adults, alone or with mood stabilizers or antidepressants
Paliperidone palmitate every 3 or 6 months (Invega Trinza, Invega Hafyera)	Maintenance after the monthly injection	Schizophrenia only
Clozapine	Refractory illness, chronic suicide risk	Approved to reduce recurrent suicidal behavior in schizophrenia or schizoaffective disorder, and for treatment-resistant schizophrenia
Lithium, valproate or carbamazepine	Bipolar type, if an antipsychotic alone is not enough	Off-label for schizoaffective disorder
Antidepressant (SSRI preferred)	Depressive type, once positive psychotic symptoms are stabilized	Off-label

Sequence (Merck): start a second-generation antipsychotic. For the bipolar type, add a mood stabilizer if needed (review lithium); for the depressive type, add an antidepressant if the depression needs treatment, SSRIs preferred, once positive psychotic symptoms are stabilized.
Paliperidone is the major active metabolite of risperidone. Like other D2 antagonists it raises prolactin, and its label carries the boxed warning for increased mortality in elderly patients with dementia-related psychosis. Class comparison: typical vs atypical antipsychotics.
Clozapine keeps its boxed warnings: severe neutropenia; orthostatic hypotension, bradycardia and syncope; seizures; myocarditis, pericarditis, cardiomyopathy and mitral valve incompetence; and increased mortality in elderly patients with dementia-related psychosis. In February 2025 FDA stopped expecting prescribers, pharmacies and patients to take part in the clozapine REMS and moved to eliminate it; the current label no longer refers to a REMS but still calls for a baseline ANC and regular ANC monitoring.
Everyone needs more than drugs: individual and family therapy, psychoeducation and community support. ECT is usually a last resort, though it can be considered to augment medication (StatPearls).

How USMLE tests it

The 2-week window can fall anywhere in the illness; it does not have to be the current episode.
"Psychosis only when manic or depressed" means a mood disorder with psychotic features, however florid the psychosis.
Any manic episode means bipolar type. For mania itself, see bipolar I vs bipolar II.
Criterion D is a real step: exclude substances, medications and medical conditions before any primary psychotic diagnosis.
Drug questions: "FDA-approved for schizoaffective disorder" is paliperidone; "reduces recurrent suicidal behavior" is clozapine.

Key takeaways

Schizoaffective disorder = major mood episode plus concurrent schizophrenia Criterion A symptoms, 2 weeks or more of delusions or hallucinations without a mood episode, and mood episodes for the majority of the illness.
Psychosis only during mood episodes: bipolar I or MDD with psychotic features.
Mood episodes for a minority of the illness: schizophrenia (6 months or more), schizophreniform disorder (1 to under 6 months) or brief psychotic disorder (under 1 month), by duration.
Any manic episode = bipolar type; major depressive episodes only = depressive type.
Since DSM-5 the rule is a majority of the illness, not "a substantial portion": judge the whole course, not one episode.
Paliperidone (oral ER tablets and monthly injection) is FDA-approved for schizoaffective disorder; clozapine is approved to reduce recurrent suicidal behavior in schizophrenia or schizoaffective disorder.